HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 21.696

Change

+0.02 (+0.08)%

Market Cap

USD 0.04B

Volume

558.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.52 (+1.13%)

USD 65.49B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+10.55 (+2.14%)

USD 12.11B
WRD:PA HSBC ETFs Public Limited Compa..

+0.60 (+1.88%)

USD 10.21B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.07 (+0.88%)

USD 8.39B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+12.35 (+2.98%)

USD 7.63B
HHH:PA HSBC ETFs Public Limited Compa..

+1.07 (+2.14%)

USD 6.87B
WLD:PA Lyxor UCITS MSCI World D-EUR

+6.29 (+1.96%)

USD 6.74B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.31 (+1.85%)

USD 6.24B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+7.62 (+2.17%)

USD 4.90B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+2.73 (+1.92%)

USD 4.56B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.73% 46% F 61% D-
Dividend Return N/A 41% F 95% A
Total Return N/A 41% F 43% F
Trailing 12 Months  
Capital Gain 14.56% 53% F 69% C-
Dividend Return N/A 64% D 45% F
Total Return N/A 71% C- 74% C
Trailing 5 Years  
Capital Gain 41.54% 50% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.54% 47% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 9.43% 63% D 63% D
Dividend Return N/A 87% B+ 98% N/A
Total Return N/A 16% F 70% C-
Risk Return Profile  
Volatility (Standard Deviation) N/A 64% D 11% F
Risk Adjusted Return N/A 46% F 16% F
Market Capitalization 0.04B 13% F 30% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.